New ultrasound technique could spot cancer in lymph nodes without a needle
NCT ID NCT07155954
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 38 times
Summary
This study is testing a new type of ultrasound called super-resolution ultrasound (SRUS) to see if it can better tell the difference between benign (non-cancerous) and malignant (cancerous) lymph nodes. About 779 adults with abnormal lymph nodes will receive an injection of ultrasound contrast agent, and then doctors will use SRUS to map tiny blood vessels inside the nodes. The goal is to improve diagnosis and potentially reduce the need for invasive biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, 100049, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ultrasound contrast agent (Sonovue/Sonazoid)
What this could lead to
If successful, this could provide a more accurate, non-invasive way to diagnose cancerous lymph nodes, reducing the need for biopsies.
What could go wrong
This is an early-stage diagnostic study, not a treatment. The technique may not prove more accurate than current methods, and results may vary across different hospitals.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.